OpenLB
Open Library of Bioscience
Advanced Search
The Lancet. Oncology
06, 2019;20 (6): e297.

CAR T-cell therapy for relapsed or refractory multiple myeloma.

Robert Stirrups
Author Information
PMID: 31085047 DOI: 10.1016/S1470-2045(19)30288-8

Abstract

No abstract text available.

MeSH Term

B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma
T-Lymphocytes

Chemicals

B-Cell Maturation Antigen
Journal Article Comment
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0CART-celltherapyrelapsedrefractorymultiplemyeloma

Similar Articles

Cited By